Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$1.25 - $5.0 $289,648 - $1.16 Million
-231,719 Closed
0 $0
Q2 2019

Aug 22, 2019

SELL
$1.65 - $6.72 $1.11 Million - $4.53 Million
-673,720 Closed
0 $0
Q1 2019

Apr 15, 2019

SELL
$4.84 - $9.07 $84,942 - $159,178
-17,550 Reduced 2.54%
673,720 $4.72 Million
Q4 2018

Feb 08, 2019

SELL
$4.21 - $14.28 $623,214 - $2.11 Million
-148,032 Reduced 17.64%
691,270 $4.33 Million
Q3 2018

Oct 29, 2018

BUY
$13.02 - $17.54 $3.96 Million - $5.34 Million
304,302 Added 56.88%
839,302 $11.8 Million
Q2 2018

Jul 26, 2018

BUY
$16.51 - $19.85 $8.83 Million - $10.6 Million
535,000 New
535,000 $8.83 Million

Others Institutions Holding ECOR

About electroCore, Inc.


  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $427M
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track Hodges Capital Management Inc. Portfolio

Follow Hodges Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hodges Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hodges Capital Management Inc. with notifications on news.